Hualan Biological Vaccine Inc. (SHE: 301207)
China flag China · Delayed Price · Currency is CNY
19.68
-0.45 (-2.24%)
Nov 15, 2024, 3:04 PM CST

Hualan Biological Vaccine Revenue

Hualan Biological Vaccine had revenue of 921.83M CNY in the quarter ending September 30, 2024, a decrease of -41.23%. This brings the company's revenue in the last twelve months to 1.65B, down -16.86% year-over-year. In the year 2023, Hualan Biological Vaccine had annual revenue of 2.41B with 32.03% growth.

Revenue (ttm)
1.65B
Revenue Growth
-16.86%
P/S Ratio
7.16
Revenue / Employee
2.14M
Employees
770
Market Cap
11.71B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.41B584.79M32.03%
Jan 1, 20231.83B-4.17M-0.23%
Jan 1, 20221.83B-596.52M-24.59%
Dec 31, 20202.43B1.38B131.30%
Dec 31, 20191.05B246.25M30.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition